Active ingredients: normal immunoglobulin
What it is used for
Intragam® 10 is indicated for replacement IgG therapy in: Primary Immunodeficiency Diseases (PID) Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. Intragam® 10 is indicated for immunomodulatory therapy in: Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count Kawasaki disease Guillain-Barre Syndrome (GBS) Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Multifocal Motor Neuropathy (MMN) Myasthenia Gravis (MG) in acute exacerbation (myasthenic crisis) or prior to surgery and/or thymectomy; as maintenance therapy for moderate to severe MG when other treatments have been ineffective or caused intolerable side effects Short-term therapy for severely affected nonparaneoplastic Lambert-Eaton Myasthenic Syndrome (LEMS) patients Treatment of significant functional impairment in patients who have a verified diagnosis of stiff person syndrome.
How to take it
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Clear or slightly opalescent, colourless to pale yellow solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems